Equity Profile

ELVN

Enliven Therapeutics, Inc.

Health CarePharmaceuticals$4.3B

Aug12Wed

Pre-Earnings Brief

UpcomingQ2-2026After Close5:00 PM EDT

Company Snapshot

Enliven Therapeutics, Inc. is a pharmaceutical company focused on developing innovative therapies to improve patient outcomes....

Key Metrics to Watch

EPS

Earnings per share is a key indicator of the company's profitability and financial health.

$-0.48

Revenue

Although no revenue is expected this quarter, any updates on future revenue potential or partnerships could be crucial.

$0M

Wall Street expectations, options signals, track record, and call prep available with Pro.

ELVN Q2-2026 Earnings Preview

Context

Company Snapshot

Enliven Therapeutics, Inc. is a pharmaceutical company focused on developing innovative therapies to improve patient outcomes. Operating in the health care sector, it aims to address unmet medical needs, which is increasingly important as the demand for effective treatments continues to grow.

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

75%

Avg EPS Surprise

+15.56%

Avg Stock Reaction

-0.48%

Last Quarter Recap

In Q1-2026, Enliven reported an EPS of $-0.38, which was better than the expected $-0.44, resulting in a slight drop in stock price the following day. The company did not provide revenue figures, indicating ongoing challenges in generating sales.

Management Promises & Guidance

Expectations

Wall Street Expectations

Analysts expect another loss this quarter, with a consensus EPS of $-0.48. Investors will be watching closely for any signs of progress in product development or partnerships.

Bull Case

If Enliven can exceed EPS expectations and provide positive updates on its pipeline, it could signal a turnaround and boost investor confidence.

Bear Case

Conversely, if the company fails to meet EPS estimates or provides no new insights into its revenue prospects, it could lead to further declines in stock price.

Key Metrics to Watch

EPS

$-0.48

Earnings per share is a key indicator of the company's profitability and financial health.

Revenue

$0M

Although no revenue is expected this quarter, any updates on future revenue potential or partnerships could be crucial.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will EPS come in better than the consensus estimate of $-0.48?

A beat on EPS could indicate improved operational efficiency and boost investor sentiment.

What updates can management provide regarding future revenue generation?

Any insights into potential partnerships or product launches could significantly impact future growth expectations.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating the potential for Enliven to surprise on EPS, given its recent trend of beating estimates.

Supporting Evidence

Enliven has a 75% EPS beat rate over the last eight quarters.

The options market is pricing a significant move, indicating that traders expect volatility which could favor a surprise.

The company's recent operational improvements may not be fully reflected in analyst estimates.

Key Risk

If the EPS comes in better than $-0.48, it could shift sentiment dramatically.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is currently cautious, and any deviation from expectations could lead to significant stock movement.

Bull Confirmed If

An EPS of better than $-0.48, coupled with positive commentary on product development, would confirm the bull case.

Bear Confirmed If

An EPS worse than $-0.52 would reinforce bearish sentiment.

Pre-Earnings Positioning

Options Market

Implied Move

±39.04%

Historical Avg

±3.0%

Pricing rich

The options market is pricing in a significant potential move, suggesting that traders expect volatility around the earnings report.

Options are pricing ±39.0% while ELVN has averaged ±3.0% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.9%

30d HV

45.5%

Calls (3K)P/C Ratio: 0.99Puts (39K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Enliven beats expectations, history suggests a potential average one-day move of +3.36%, confirming a positive outlook.

In-Line / Cautious

If results are in line with expectations, the stock may see muted movement, reflecting ongoing uncertainty.

Miss

Should the company miss expectations, history suggests an average one-day move of -1.62%, likely leading to further declines.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on product pipeline advancements or partnerships.
2Management's commentary on cost management and operational efficiency.
3Insights into potential revenue streams or market opportunities.
4Details on any ongoing clinical trials or regulatory approvals.
5Guidance on future earnings expectations or strategic initiatives.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Aug10

BWBMO

Babcock & Wilcox Enterprises, Inc.

PreviewView

Aug10

ROIVBMO

Company Snapshot

Enliven Therapeutics, Inc. is a pharmaceutical company focused on developing innovative therapies to improve patient outcomes....

Key Metrics to Watch

EPS

Earnings per share is a key indicator of the company's profitability and financial health.

$-0.48

Revenue

Although no revenue is expected this quarter, any updates on future revenue potential or partnerships could be crucial.

$0M

Wall Street expectations, options signals, track record, and call prep available with Pro.

ELVN Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

75%

Avg EPS Surprise

+15.56%

Avg Stock Reaction

-0.48%

Last Quarter Recap

Management Promises & Guidance

Expectations

Wall Street Expectations

Analysts expect another loss this quarter, with a consensus EPS of $-0.48. Investors will be watching closely for any signs of progress in product development or partnerships.

Bull Case

If Enliven can exceed EPS expectations and provide positive updates on its pipeline, it could signal a turnaround and boost investor confidence.

Bear Case

Conversely, if the company fails to meet EPS estimates or provides no new insights into its revenue prospects, it could lead to further declines in stock price.

Key Metrics to Watch

EPS

$-0.48

Earnings per share is a key indicator of the company's profitability and financial health.

Revenue

$0M

Although no revenue is expected this quarter, any updates on future revenue potential or partnerships could be crucial.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will EPS come in better than the consensus estimate of $-0.48?

A beat on EPS could indicate improved operational efficiency and boost investor sentiment.

What updates can management provide regarding future revenue generation?

Any insights into potential partnerships or product launches could significantly impact future growth expectations.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating the potential for Enliven to surprise on EPS, given its recent trend of beating estimates.

Supporting Evidence

Enliven has a 75% EPS beat rate over the last eight quarters.

The options market is pricing a significant move, indicating that traders expect volatility which could favor a surprise.

The company's recent operational improvements may not be fully reflected in analyst estimates.

Key Risk

If the EPS comes in better than $-0.48, it could shift sentiment dramatically.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is currently cautious, and any deviation from expectations could lead to significant stock movement.

Bull Confirmed If

An EPS of better than $-0.48, coupled with positive commentary on product development, would confirm the bull case.

Bear Confirmed If

An EPS worse than $-0.52 would reinforce bearish sentiment.

Pre-Earnings Positioning

Options Market

Implied Move

±39.04%

Historical Avg

±3.0%

Pricing rich

The options market is pricing in a significant potential move, suggesting that traders expect volatility around the earnings report.

Options are pricing ±39.0% while ELVN has averaged ±3.0% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.9%

30d HV

45.5%

Calls (3K)P/C Ratio: 0.99Puts (39K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Enliven beats expectations, history suggests a potential average one-day move of +3.36%, confirming a positive outlook.

In-Line / Cautious

If results are in line with expectations, the stock may see muted movement, reflecting ongoing uncertainty.

Miss

Should the company miss expectations, history suggests an average one-day move of -1.62%, likely leading to further declines.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on product pipeline advancements or partnerships.
2Management's commentary on cost management and operational efficiency.
3Insights into potential revenue streams or market opportunities.
4Details on any ongoing clinical trials or regulatory approvals.
5Guidance on future earnings expectations or strategic initiatives.